The landscape of oncology is undergoing a seismic shift. For decades, the cancer care paradigm was anchored in the clinic—a rigid, centralized model of chemotherapy infusions and radiation therapy. Today, that model is evolving. As medical innovation accelerates, patients are increasingly transitioning to complex, personalized treatment regimens that are managed primarily within the home.
While this shift offers greater autonomy, it introduces a labyrinth of challenges for patients already facing the physical and emotional toll of a cancer diagnosis. Managing oral therapies, navigating intricate dosing schedules, and balancing cancer treatment with existing comorbidities—such as diabetes or hypertension—requires a level of coordination that extends far beyond the traditional doctor-patient visit. To bridge this gap, Walgreens Specialty Pharmacy has implemented the "Specialty360" model, an integrated, holistic approach designed to ensure that patients do not just survive, but thrive, during their treatment journey.
The Shift: Why Holistic Care Matters Now More Than Ever
The modern oncology patient is rarely dealing with cancer in a vacuum. They are juggling home life, financial constraints, secondary health conditions, and the daunting logistics of specialized medication.
"Patients aren’t just their cancer condition," explains Laly Havern, director of clinical pharmacy strategy, oncology at Walgreens Specialty Pharmacy. "They may be struggling with other conditions or have financial barriers, and we’re focused on the whole patient to meet their unique needs."
This focus has yielded significant results. Walgreens Specialty Pharmacy reports a 92% medication adherence rate—notably higher than the 80% industry benchmark. This success is not merely the result of efficient fulfillment; it is the outcome of a deliberate strategy to show up in the "moments between appointments."
Chronology of Care: A Patient’s Journey Through Specialty360
The Walgreens Specialty360 model is built on a multidisciplinary foundation, integrating oncology-trained pharmacists, nurses, dietitians, and benefits specialists. The journey is categorized into distinct phases that ensure no patient is left to navigate the complexities alone.
Phase 1: The Pre-Treatment Strategy
The complexity of cancer care begins the moment a prescription is written. Before a patient takes their first dose, Walgreens teams perform a comprehensive intake. They review the patient’s clinical history, identify potential drug-to-drug interactions with existing medications, and anticipate financial hurdles.
Darren McLane, senior director of clinical services at Walgreens Specialty Pharmacy, notes that every drug comes with its own unique administrative and financial fingerprint. "Our teams are built to anticipate those needs early," McLane says. "By coordinating with oncology clinics on prior authorizations and reimbursement requirements, we eliminate the administrative friction that can delay life-saving treatment."
Phase 2: Financial Navigation and Advocacy
Even when treatment is approved, the cost of specialty oncology medication can be prohibitive. Walgreens employs a dual-layered approach to this challenge: a dedicated billing and reimbursement team paired with digital platforms like TailorMed. This technology scans for copay assistance programs, grants, and foundation support.
The efficacy of this strategy is evidenced by 2024 data, which revealed that 56% of Walgreens Specialty Pharmacy patients paid $0 out of pocket for their cancer therapies and related conditions. This is a crucial intervention, as Havern highlights: "It doesn’t do the patient any good to get a same-day drug with a $500 copay if taking an extra day could reduce that cost to zero."
Phase 3: Home-Based Education and Cycle Management
As treatment moves into the home, the pharmacy becomes the primary hub for education. Sarah Schmidt, an oncology pharmacist based in Wauwatosa, Wisconsin, emphasizes that the first step is empowerment through knowledge.
"From the first onboarding, we do a thorough review of the medication," Schmidt explains. "Many oncology therapies involve complex, cycled dosing schedules that must be perfectly aligned with infusion appointments. We create personalized calendars for patients, allowing them to track their progress and manage their medication rhythm with confidence."
Phase 4: Ongoing Symptom Management
The Specialty360 model includes rigorous, ongoing screening. Every consultation involves a review of potential treatment-related side effects. The data is compelling: through these proactive screens, pharmacists identified that 47% of patients had not been prescribed necessary antinausea medication, despite clinical guidelines recommending it. By flagging this to providers, the pharmacy team ensures that quality-of-life symptoms are addressed before they become debilitating.
Supporting the Whole-Patient Experience
Modern oncology care is increasingly acknowledging that a patient’s well-being is tied to more than just tumor shrinkage. It encompasses mental health, physical appearance, nutrition, and future planning.
Mental Health and Social Support
Walgreens teams are trained to identify signs of anxiety and depression, which are prevalent in the cancer community. Furthermore, for those who must travel long distances for specialized care, the pharmacy helps coordinate logistical support, including local housing assistance.
The "Feel More Like You" Initiative
Visible side effects, such as hair loss or skin changes, can significantly impact a patient’s self-esteem and mental health. Through the Feel More Like You® service, beauty and wellness consultants at retail locations recommend products vetted specifically for their safety during chemotherapy and radiation, providing a sense of normalcy and dignity during a traumatic period.
Nutritional and Fertility Advocacy
Nutrition is a critical but often overlooked aspect of oncology. Recognizing that therapies can alter taste and dietary tolerance, Walgreens recently launched a dietitian-led program to provide oncology-specific nutritional counseling.
Perhaps the most sensitive area is fertility. For younger patients, cancer treatment can jeopardize future family planning. Walgreens teams actively track whether these critical conversations have taken place. Before this initiative, nearly 20% of patients had not discussed fertility preservation options with their care team. By stepping in to facilitate these consultations, Walgreens ensures that patients are empowered to make decisions that align with their long-term life goals.
Supporting Data and Clinical Implications
The effectiveness of the Specialty360 model is rooted in data-driven interventions. By integrating pharmacy services into the patient’s daily life, Walgreens has moved beyond the transactional nature of filling prescriptions.
- Medication Adherence: 92% vs. 80% industry benchmark.
- Financial Relief: 56% of patients reported $0 out-of-pocket costs in the first half of 2024.
- Proactive Care: 100% of oncology patients screened for treatment-related symptoms, identifying critical gaps in supportive care (such as missing antinausea medication for 47% of those screened).
- Preventative Consultation: 20% of patients identified as needing fertility counseling who had not previously received it.
Conclusion: The Future of Personalized Oncology
The evolution of cancer care is fundamentally about recognizing the patient as a person rather than a diagnosis. As treatments become more sophisticated, the support systems around those treatments must become equally advanced.
"Our goal is not to delay therapy," says Laly Havern, "but to ensure patients feel informed, supported, and empowered to make choices that align with their goals."
As oncology continues to shift toward home-based, patient-led models, the "everyday work" of pharmacy teams—the check-ins, the calendars, the financial advocacy, and the emotional support—is becoming the silent engine of success. For patients facing the fight of their lives, this integrated, 360-degree approach provides more than just medicine; it provides a roadmap for navigating the complexities of cancer with clarity, agency, and hope.
Sources
- Walgreens internal data.
- January 1, 2024 – June 30, 2024. Walgreens Specialty Pharmacy internal reporting, K. Khan, July 15, 2024.
- Walgreens internal data.
- Walgreens internal data.
About the Author
